EP3143047
BELIMUMAB FORMULATION
:
EP einkaleyfi: Þýðing ekki lögð inn:
15.5.2015:
20.7.2022:
15724070.6
:
14.5.2035
:
BELIMUMAB FORMULATION
15.5.2015
20.7.2022
:
GlaxoSmithKline Intellectual Property Management Limited:
980 Great West Road, Brentford, Middlesex TW8 9GS, GB
:
BLAKE-HASKINS, Angela:
Gaithersburg, Maryland 20878, US
:
MARSHALL, Tristan:
Rockville, Maryland 20850, US
:
O'BERRY, Kristen:
Gaithersburg, Maryland 20878, US
:
PERKINS, Melissa D.:
McPherson, Kansas 67460, US
:
201461994427 P:
16.5.2014:
US
:
201462093734 P:
18.12.2014:
US
:
201462095181 P:
22.12.2014:
US
:
IB2015053602:
15.5.2015
:
C07K 16/28, A61K 39/395